florbetazine
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 6, 2023 (NCT06593626)
Timeline
No events for the selected filters.
Indications
Studied for
Mechanism of action
- Amyloid beta precursor like protein 1BINDING AGENT
APLP1 binding agent
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06593626 | Phase 1 | Nov 6, 2023 | — |
Showing 1 of 1 trials
Page 1 / 1